Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study - Akizawa, Tadao; Origasa, Hideki; Kameoka, Chisato; Kaneko, Yuichiro; Kanoh, Hiroyuki (Therapeutic apheresis and dialysis, 2014)
Keywords: Bixalomer; Chelating Agents - therapeutic use; Dose-finding; Dose-Response Relationship, Drug; Double-Blind Method; Hemodialysis; Hyperphosphatemia; Hyperphosphatemia - blood; Hyperphosphatemia - drug therapy; Hyperphosphatemia - etiology; Japan; Kidney disease; Phosphorus - blood; Polyamines - blood; Polyamines - therapeutic use; Randomized controlled trial; Renal Dialysis - adverse effects; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - therapy; Sevelamer; Treatment Outcome; Japan; Bixalomer; Kidney disease; Dose-finding; Hyperphosphatemia; Hemodialysis; Randomized controlled trial